


Searching News Database: Affymetrix
HSMN NewsFeed - 11 Feb 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
HSMN NewsFeed - 18 Feb 2015
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
HSMN NewsFeed - 1 Jun 2011
Affymetrix Appoints Frank Witney, Ph.D., as President and Chief Executive Officer
Affymetrix Appoints Frank Witney, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 13 Oct 2010
BioScale Appoints Peter H. Lewis as Vice President of Finance and Administration
BioScale Appoints Peter H. Lewis as Vice President of Finance and Administration
HSMN NewsFeed - 3 Mar 2010
Affymetrix Appoints Jami Dover Nachtsheim and Nelson C. Chan to Board of Directors
Affymetrix Appoints Jami Dover Nachtsheim and Nelson C. Chan to Board of Directors
HSMN NewsFeed - 17 Feb 2010
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
HSMN NewsFeed - 7 May 2009
Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast Cancer
Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast Cancer
HSMN NewsFeed - 2 Dec 2008
BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
HSMN NewsFeed - 31 Jul 2008
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
HSMN NewsFeed - 10 May 2007
La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer
La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer
Additional items found! 30
Members Archive contains
30 additional stories matching:
Affymetrix
(Password required)
Affymetrix
(Password required)
